dc.contributor.author | Okoliegbe, Ijeoma N. | |
dc.contributor.author | Hijazi, Karolin | |
dc.contributor.author | Cooper, Kim | |
dc.contributor.author | Ironside, Corinne | |
dc.contributor.author | Gould, Ian M | |
dc.date.accessioned | 2021-08-13T10:53:01Z | |
dc.date.available | 2021-08-13T10:53:01Z | |
dc.date.issued | 2021-08-12 | |
dc.identifier.citation | Okoliegbe , I N , Hijazi , K , Cooper , K , Ironside , C & Gould , I M 2021 , ' Antimicrobial Synergy Testing : Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived ' , Antibiotics , vol. 10 , no. 8 , 967 . https://doi.org/10.3390/antibiotics10080967 | en |
dc.identifier.issn | 2079-6382 | |
dc.identifier.other | PURE: 198420491 | |
dc.identifier.other | PURE UUID: 29532e3a-2dfa-4ee8-910d-fe16bffe8e8a | |
dc.identifier.other | Scopus: 85113761255 | |
dc.identifier.other | WOS: 000688660900001 | |
dc.identifier.uri | https://hdl.handle.net/2164/16945 | |
dc.description | Funding: This research was funded by the NHS Grampian Endowment fund, grant number EA9431, and the NHS Grampian Clinical Microbiology Fund (NHS Grampian Endowment Funds, Registered Charity Number SC017296). Acknowledgments: The authors would like to thank the laboratories and clinicians who use the Cystic Fibrosis Susceptibility Testing Service. CFASS is an adult patient-testing facility, funded by the National Services Division of the Common Services Agency of the Scottish Executive. | en |
dc.format.extent | 12 | |
dc.language.iso | eng | |
dc.relation.ispartof | Antibiotics | en |
dc.rights | © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). | en |
dc.subject | antimicrobials | en |
dc.subject | ceftazidime | en |
dc.subject | combination antimicrobial susceptibility testing | en |
dc.subject | gradient diffusion | en |
dc.subject | Pseudomonas aeruginosa | en |
dc.subject | synergy testing | en |
dc.subject | tobramycin | en |
dc.subject | R Medicine | en |
dc.subject | RK Dentistry | en |
dc.subject | Other | en |
dc.subject | EA9431 | en |
dc.subject | Supplementary Information | en |
dc.subject.lcc | R | en |
dc.subject.lcc | RK | en |
dc.title | Antimicrobial Synergy Testing : Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Dental Education | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.3390/antibiotics10080967 | |
dc.identifier.vol | 10 | en |
dc.identifier.iss | 8 | en |